Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Teruel

4 clinical trials in Teruel, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Teruel at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

4 trials in Teruel

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Fundacion Instituto De Investigacion Sanitaria Aragon
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tinzaparin Sodium
  • Sponsor:Grupo Gallego De Investigacion En Tumores Digestivos

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Teruel

What the registry says about research in the country

01 Oncology Research

Investigating preventive measures for venous thromboembolic disease in patients with metastatic colorectal cancer. The research focuses on evaluating prophylactic treatments during first-line therapy.

  • Colorectal Cancer Management
  • Thrombosis Prevention
  • Systemic Treatment Optimization

Studies aim to improve patient outcomes during chemotherapy and targeted therapy combinations.

02 Gastroenterology Studies

Examining the safety of cold snare polypectomy procedures in patients maintaining anticoagulant and antiplatelet therapies. Research focuses on minimizing bleeding risks during routine colonoscopy procedures.

  • Polyp Removal Techniques
  • Bleeding Risk Assessment
  • Anticoagulation Management

The research aims to establish safer protocols for patients requiring ongoing blood-thinning medications.

03 Breast Cancer Research

Evaluating extended therapy with camizestrant in ER+/HER2- early breast cancer patients. The study focuses on preventing cancer recurrence after standard adjuvant endocrine therapy.

  • Extended Therapy Efficacy
  • Recurrence Prevention
  • Endocrine Treatment Innovation

This research represents advancement in personalized treatment approaches for breast cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).